HPLC fingerprinting/GC-MS analysis, and efficacy of Hypericum perforatum against cisplatin-induced hepato-renal toxicity in mice with insights into the TXNIP/NLRP3 pathway

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Salem M.B.; Morsi E.A.; El-Wakil E.A.; El-Lakkany N.M.; Abou-shousha T.; Abdel-Hady H.

Journal: Journal of Applied Pharmaceutical Science

Publisher: Open Science Publishers LLP Inc.

Publication Date: 1 September 2023

Volume / Issue: Volume 13 / Issue 9

Pages: 37–47

ISSN: 22313354

DOI: 10.7324/JAPS.2023.6683

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access


Authors and Affiliations

Salem M.B., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; Morsi E.A., Medicinal Chemistry Department, Theodor Bilharz Research Institute, Giza, Egypt; El-Wakil E.A., Medicinal Chemistry Department, Theodor Bilharz Research Institute, Giza, Egypt; El-Lakkany N.M., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; Abou-shousha T., Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt; Abdel-Hady H., Medicinal Chemistry Department, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Hypericum perforatum (HP) has antioxidant and anti-inflammatory characteristics. Nevertheless, its anti-inflammatory effects against hepato-renal injury have not been investigated. Therefore, this survey is designed to evaluate the prophylactic effect of HP extract against cisplatin- (CDDP-) induced hepato-renal toxicity in mice. Also, the active ingredients of HP were recognized. Hepato-renal toxicity was prompted by a single dose of CDDP (13 mg/kg, intraperitoneally). HP was tested at 50, 100, and 200 mg/kg/day for 10 days. Liver and kidney enzymes, oxidative stress, and inflammatory markers were examined, and histopathological examinations were performed. Total phenolic and flavonoid contents, besides 2,2-diphenyl-l-picrylhydrazyl radical scavenging activity, were assessed by identifying HP chemical compounds through high-performance liquid chromatography (HPLC) fingerprinting and gas chromatography-mass spectrometry. HP at 200 mg/kg improved hepatic and renal biochemical markers, reduced oxidative stress, and restored normal liver and kidney histology. Moreover, HP reduced inflammation by inhibiting TXNIP and NLRP3 tissue contents and cleaved caspase-1, interleukin-1β, and nuclear factor kappa-β expressions. The HPLC fingerprinting revealed high concentrations of ellagic acids, cinnamic acids, quercetin, and hesperidin, which may be responsible for alleviating hepato-renal damage. HP is an effective therapeutic agent against CDDP-induced hepato-renal toxicity and could be a realistic adjuvant therapy with CDDP for cancer treatment. © 2023 Maha Badr Salem et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).


Keywords

cisplatin; Hypericum perforatum; inflammasome pathway; oxidative stress; phenolic compounds; alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; biological marker; cinnamic acid; cryopyrin; ellagic acid; flavonoid; hesperidin; Hypericum perforatum extract; immunoglobulin enhancer binding protein; interleukin 1beta; interleukin 1beta converting enzyme; malonaldehyde; phenol derivative; phytochemical; quercetin; thiopental; thioredoxin interacting protein; animal experiment; animal tissue; antioxidant activity; Article; blood analysis; body weight; cancer therapy; DPPH radical scavenging assay; enzyme linked immunosorbent assay; experimental design; high performance liquid chromatography; histology; histopathology; inflammation; kidney injury; liver injury; liver toxicity; male; mass fragmentography; mouse; nephrotoxicity; nonhuman; real time polymerase chain reaction; relative kidney weight; relative liver weight; relative organ weight; retention time; RNA extraction; single drug dose; Swiss Webster mouse


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]